NCT05070247 2026-01-22
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Phase 1/2 Terminated
Takeda
Brown University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Geriatric Oncology Consortium